(S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN method)) (SBAR (S (VP (TO to) (VP (ADVP (RB successfully)) (VB detect) (NP (DT the) (NNP ADRs)) (S (VP (VBG using) (NP (NP (NN feature) (NN matrix)) (CC and) (NP (NN feature) (NN selection))))))))))) (. .))
(S (NP (NP (DT A) (NN feature) (NN matrix)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ characterizes) (NP (NP (DT the) (JJ medical) (NNS events)) (SBAR (SBAR (IN before) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs))))) (CC or) (SBAR (IN after) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs)))))))))) (, ,)) (VP (VBZ is) (VP (VBN created) (PP (IN from) (NP (NNP THIN) (NN database))))) (. .))
(S (NP (NP (DT The) (NN feature) (NN selection) (NN method)) (PP (IN of) (NP (NP (NNP Student) (POS 's)) (NN t-test)))) (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NP (DT the) (JJ significant) (NNS features)) (PP (IN from) (NP (NP (NNS thousands)) (PP (IN of) (NP (JJ medical) (NNS events))))))))))) (. .))
(S (NP (NP (DT The) (JJ significant) (NNP ADRs)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBG corresponding) (PP (TO to) (NP (JJ significant) (NNS features))))))) (, ,)) (VP (VBP are) (VP (VBN detected))) (. .))
(S (NP (NNS Experiments)) (VP (VBP are) (VP (VBN performed) (PP (IN on) (NP (NP (DT the) (NN drug)) (NP (NNP Pioglitazone)))))) (. .))
(S (PP (VBN Compared) (PP (TO to) (NP (JJ other) (JJ computerized) (NNS methods)))) (, ,) (NP (PRP$ our) (VBN proposed) (NN method)) (VP (VBZ achieves) (NP (JJ good) (NN performance))) (. .))
